start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=279
end-page=283
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=The 172th Okayama Surgical Society
kn-title=‘æ172‰ñ�@‰ªŽRŠO‰È‰ï
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=
en-copyright=
kn-copyright=

en-aut-name=
en-aut-sei=
en-aut-mei=
kn-aut-name=“¡Œ´�r‹`
kn-aut-sei=“¡Œ´
kn-aut-mei=�r‹`
aut-affil-num=1
ORCID=

affil-num=1
en-affil=
kn-affil=
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=275
end-page=277
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=Okayama Prefectural Culture Prize (Academic Category)
kn-title=‰ªŽRŒ§•¶‰»�Ü�iŠw�p•”–å�CˆãŠw•ª–ì�j‚ðŽó�Ü‚µ‚Ä
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=
en-copyright=
kn-copyright=

en-aut-name=NishiboriMasahiro
en-aut-sei=Nishibori
en-aut-mei=Masahiro
kn-aut-name=�¼–x�³—m
kn-aut-sei=�¼–x
kn-aut-mei=�³—m
aut-affil-num=1
ORCID=

affil-num=1
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@–ò—�Šw
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=273
end-page=274
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=
kn-title=“ú–{—X�­Š”Ž®‰ïŽÐ �L“‡’ü�M•a‰@
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=
en-copyright=
kn-copyright=

en-aut-name=
en-aut-sei=
en-aut-mei=
kn-aut-name=ˆä�ã�ƒˆê
kn-aut-sei=ˆä�ã
kn-aut-mei=�ƒˆê
aut-affil-num=1
ORCID=

affil-num=1
en-affil=
kn-affil=
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=271
end-page=272
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=
kn-title=�L“‡Žs—§�L“‡Žs–¯•a‰@
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=
en-copyright=
kn-copyright=

en-aut-name=
en-aut-sei=
en-aut-mei=
kn-aut-name=‘å’뎡
kn-aut-sei=‘å’ë
kn-aut-mei=Ž¡
aut-affil-num=1
ORCID=

affil-num=1
en-affil=
kn-affil=
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=269
end-page=270
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=
kn-title=�ÀŒG•a‰@
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=
en-copyright=
kn-copyright=

en-aut-name=
en-aut-sei=
en-aut-mei=
kn-aut-name=•½—ÑŒõŽi
kn-aut-sei=•½—Ñ
kn-aut-mei=ŒõŽi
aut-affil-num=1
ORCID=

affil-num=1
en-affil=
kn-affil=
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=265
end-page=267
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=Carotid artery stenosis
kn-title=èò•”èò“®–¬‹·�ó�Ç
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=
en-copyright=
kn-copyright=

en-aut-name=OkumaYu
en-aut-sei=Okuma
en-aut-mei=Yu
kn-aut-name=‘åŒF—C
kn-aut-sei=‘åŒF
kn-aut-mei=—C
aut-affil-num=1
ORCID=

affil-num=1
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@”]�_ŒoŠO‰ÈŠw
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=259
end-page=264
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=Drug interaction (19. combination with antiparkinson agents)
kn-title=–ò•¨‘ŠŒÝ�ì—p�i19�\ƒp�[ƒLƒ“ƒ\ƒ“•aŽ¡—Öò‚Ì–ò•¨‘ŠŒÝ�ì—p�j
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=
en-copyright=
kn-copyright=

en-aut-name=EzumiSatoru
en-aut-sei=Ezumi
en-aut-mei=Satoru
kn-aut-name=�]ŠpŒå
kn-aut-sei=�]Šp
kn-aut-mei=Ό
aut-affil-num=1
ORCID=

en-aut-name=KurodaSatoshi
en-aut-sei=Kuroda
en-aut-mei=Satoshi
kn-aut-name=�•“c’q
kn-aut-sei=�•“c
kn-aut-mei=’q
aut-affil-num=2
ORCID=

en-aut-name=MatsunagaHisashi
en-aut-sei=Matsunaga
en-aut-mei=Hisashi
kn-aut-name=�¼‰i�®
kn-aut-sei=�¼‰i
kn-aut-mei=�®
aut-affil-num=3
ORCID=

en-aut-name=SendoToshiaki
en-aut-sei=Sendo
en-aut-mei=Toshiaki
kn-aut-name=�ç“°”N�º
kn-aut-sei=�瓰
kn-aut-mei=”N�º
aut-affil-num=4
ORCID=

affil-num=1
en-affil=
kn-affil=‰ªŽR‘åŠw•a‰@�@–ò�Ü•”

affil-num=2
en-affil=
kn-affil=‰ªŽR‘åŠw•a‰@�@–ò�Ü•”

affil-num=3
en-affil=
kn-affil=‰ªŽR‘åŠw•a‰@�@–ò�Ü•”

affil-num=4
en-affil=
kn-affil=‰ªŽR‘åŠw•a‰@�@–ò�Ü•”
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=253
end-page=257
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=Japanese guidelines for the treatment of hip fractures in the elderly
kn-title=‘å‘Ú�œŒz•”�E“]Žq•”�œ�܂̃KƒCƒhƒ‰ƒCƒ“
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=
en-copyright=
kn-copyright=

en-aut-name=NodaTomoyuki
en-aut-sei=Noda
en-aut-mei=Tomoyuki
kn-aut-name=–ì“c’m”V
kn-aut-sei=–ì“c
kn-aut-mei=’m”V
aut-affil-num=1
ORCID=

en-aut-name=OzakiToshifumi
en-aut-sei=Ozaki
en-aut-mei=Toshifumi
kn-aut-name=”öú±•q•¶
kn-aut-sei=”öú±
kn-aut-mei=•q•¶
aut-affil-num=2
ORCID=

affil-num=1
en-affil=
kn-affil=‰ªŽR‘åŠw•a‰@�@�®Œ`ŠO‰È

affil-num=2
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@�®Œ`ŠO‰ÈŠw
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=249
end-page=251
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=Evidence-based guidelines for the management of biliary tract cancer
kn-title=’_“¹Šà�f—ÃKƒCƒhƒ‰ƒCƒ“
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=
en-copyright=
kn-copyright=

en-aut-name=FujiiMasakuni
en-aut-sei=Fujii
en-aut-mei=Masakuni
kn-aut-name=“¡ˆä‰ë–M
kn-aut-sei=“¡ˆä
kn-aut-mei=‰ë–M
aut-affil-num=1
ORCID=

en-aut-name=KawamotoHirofumi
en-aut-sei=Kawamoto
en-aut-mei=Hirofumi
kn-aut-name=‰Í–{”Ž•¶
kn-aut-sei=‰Í–{
kn-aut-mei=”Ž•¶
aut-affil-num=2
ORCID=

en-aut-name=YamamotoKazuhide
en-aut-sei=Yamamoto
en-aut-mei=Kazuhide
kn-aut-name=ŽR–{˜a�G
kn-aut-sei=ŽR–{
kn-aut-mei=˜a�G
aut-affil-num=3
ORCID=

affil-num=1
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@�Á‰»Ší�EŠÌ‘Ÿ“à‰ÈŠw

affil-num=2
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@�Á‰»Ší�EŠÌ‘Ÿ“à‰ÈŠw

affil-num=3
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@�Á‰»Ší�EŠÌ‘Ÿ“à‰ÈŠw
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=243
end-page=247
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=A view of clinical guidelines for acute cholangitis and cholecystitis
kn-title=‹}�«’_ŠÇ‰Š�E’_”X‰Š‚Ì�f—ÃKƒCƒhƒ‰ƒCƒ“‚ɂ‚¢‚Ä
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=
en-copyright=
kn-copyright=

en-aut-name=TsutsumiKoichiro
en-aut-sei=Tsutsumi
en-aut-mei=Koichiro
kn-aut-name=’ç�Nˆê˜Y
kn-aut-sei=’ç
kn-aut-mei=�Nˆê˜Y
aut-affil-num=1
ORCID=

en-aut-name=KawamotoHirofumi
en-aut-sei=Kawamoto
en-aut-mei=Hirofumi
kn-aut-name=‰Í–{”Ž•¶
kn-aut-sei=‰Í–{
kn-aut-mei=”Ž•¶
aut-affil-num=2
ORCID=

en-aut-name=YamamotoKazuhide
en-aut-sei=Yamamoto
en-aut-mei=Kazuhide
kn-aut-name=ŽR–{˜a�G
kn-aut-sei=ŽR–{
kn-aut-mei=˜a�G
aut-affil-num=3
ORCID=

affil-num=1
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@�Á‰»Ší�EŠÌ‘Ÿ“à‰ÈŠw

affil-num=2
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@�Á‰»Ší�EŠÌ‘Ÿ“à‰ÈŠw

affil-num=3
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@�Á‰»Ší�EŠÌ‘Ÿ“à‰ÈŠw
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=237
end-page=242
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=The present status of rare diseases in Japan
kn-title=Šó�­Ž¾Š³‚Æ‚»‚ê‚ç‚ւ̑Ήž
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=
en-copyright=
kn-copyright=

en-aut-name=TanimotoMitsune
en-aut-sei=Tanimoto
en-aut-mei=Mitsune
kn-aut-name=’J–{Œõ‰¹
kn-aut-sei=’J–{
kn-aut-mei=Œõ‰¹
aut-affil-num=1
ORCID=

affil-num=1
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@ŒŒ‰t�EŽîá‡�EŒÄ‹zŠí�EƒAƒŒƒ‹ƒM�[“à‰ÈŠw
en-keyword=Šó�­Ž¾Š³
kn-keyword=Šó�­Ž¾Š³
en-keyword=orphan drug
kn-keyword=orphan drug
en-keyword=“�«Ž¾Š³
kn-keyword=“�«Ž¾Š³
en-keyword=ˆã–ò•iŠJ”­
kn-keyword=ˆã–ò•iŠJ”­
en-keyword=�V–ò�³”F
kn-keyword=�V–ò�³”F
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=231
end-page=236
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=A case of transverse colon cancer with remarkable extramural invasion to stomach and jejunum
kn-title=•ÇŠO�«‚ÉŽîᎂðŒ`�¬‚µˆÝ�E�¬’°�Z��‚ðŽ¦‚µ‚½‰¡�sŒ‹’°Šà‚Ì‚P—á
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=A 77-year-old woman was admitted to our hospital due to abdominal pain and body weight loss. A palpable mass the size of an infant's head was tender on palpation and identified as an epigastric lesion. Colonoscopic examination revealed stenosis of the transverse colon, although no intraluminal growth of the tumor was found. The histologic findings of the biopsy material were poorly differentiated and/or undifferentiated cells. Abdominal CT scan showed an irregular-shaped tumor with a diameter of 10cm invading the stomach and jejunum. We performed an operation under a diagnosis of extramurally growing cancer or malignant lymphoma of the colon. Partial resection of the transverse colon was done by distal gastrectomy and partial resection of the jejunum. Histologic examination of the operative specimens revealed moderately differentiated adenocarcinoma of the transverse colon, prominently proliferating into the surrounding tissues. The finding of a long stenotic lesion and extramural compression by colonography are characteristic of this tumor, based on a review of 43 literature reports in Japan.
en-copyright=
kn-copyright=

en-aut-name=HamanoRyosuke
en-aut-sei=Hamano
en-aut-mei=Ryosuke
kn-aut-name=à_–ì—º•ã
kn-aut-sei=à_–ì
kn-aut-mei=—º•ã
aut-affil-num=1
ORCID=

en-aut-name=OtsukaShinya
en-aut-sei=Otsuka
en-aut-mei=Shinya
kn-aut-name=‘å’ËáÁ�Æ
kn-aut-sei=‘å’Ë
kn-aut-mei=áÁ�Æ
aut-affil-num=2
ORCID=

en-aut-name=KimuraYuuji
en-aut-sei=Kimura
en-aut-mei=Yuuji
kn-aut-name=–Ø‘º—TŽi
kn-aut-sei=ЯԼ
kn-aut-mei=—TŽi
aut-affil-num=3
ORCID=

en-aut-name=NishieManabu
en-aut-sei=Nishie
en-aut-mei=Manabu
kn-aut-name=�¼�]Šw
kn-aut-sei=�¼�]
kn-aut-mei=Šw
aut-affil-num=4
ORCID=

en-aut-name=TokunagaNaoyuki
en-aut-sei=Tokunaga
en-aut-mei=Naoyuki
kn-aut-name=“¿‰i�®”V
kn-aut-sei=“¿‰i
kn-aut-mei=�®”V
aut-affil-num=5
ORCID=

en-aut-name=MiyasouHideaki
en-aut-sei=Miyasou
en-aut-mei=Hideaki
kn-aut-name=‹{�@�G–¾
kn-aut-sei=‹{�@
kn-aut-mei=�G–¾
aut-affil-num=6
ORCID=

en-aut-name=TsunemituYousuke
en-aut-sei=Tsunemitu
en-aut-mei=Yousuke
kn-aut-name=�íŒõ—m•ã
kn-aut-sei=�íŒõ
kn-aut-mei=—m•ã
aut-affil-num=7
ORCID=

en-aut-name=InagakiMasaru
en-aut-sei=Inagaki
en-aut-mei=Masaru
kn-aut-name=ˆîŠ_—D
kn-aut-sei=ˆîŠ_
kn-aut-mei=—D
aut-affil-num=8
ORCID=

en-aut-name=IwakawaKazuhide
en-aut-sei=Iwakawa
en-aut-mei=Kazuhide
kn-aut-name=Šâ�ì˜a�G
kn-aut-sei=Šâ�ì
kn-aut-mei=˜a�G
aut-affil-num=9
ORCID=

en-aut-name=IwagakiHiromi
en-aut-sei=Iwagaki
en-aut-mei=Hiromi
kn-aut-name=ŠâŠ_”Ž–¤
kn-aut-sei=ŠâŠ_
kn-aut-mei=”Ž–¤
aut-affil-num=10
ORCID=

affil-num=1
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠO‰È

affil-num=2
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠO‰È

affil-num=3
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠO‰È

affil-num=4
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠO‰È

affil-num=5
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠO‰È

affil-num=6
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠO‰È

affil-num=7
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠO‰È

affil-num=8
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠO‰È

affil-num=9
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠO‰È

affil-num=10
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠO‰È
en-keyword=‘å’°Šà (colon cancer)
kn-keyword=‘å’°Šà (colon cancer)
en-keyword=•ÇŠO�«”­ˆç (extraluminal growth)
kn-keyword=•ÇŠO�«”­ˆç (extraluminal growth)
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=225
end-page=229
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=Usefulness of the waterless method for surgical hand washing�FA comparison with the conventional scrub method
kn-title=Žè�pŽžŽè�ô‚¢‚É‚¨‚¯‚é�]—ˆ–@‚ƃc�[ƒXƒe�[ƒW�EƒT�[ƒWƒJƒ‹ƒXƒNƒ‰ƒu–@�CƒEƒH�[ƒ^�[ƒŒƒX–@‚Ì”äŠr‚ɂ‚¢‚Ä
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=To evaluate the usefulness of the waterless hand washing method for surgical anti-sepsis, we conducted a microbial sampling study, comparing it to a conventional surgical scrub method. A total of 18 operating-room nurses were undertaking the following three-hand washing protocols : scrubbing with blushes using 4w/v% chlorhexidine gluconate (CHG) and also rubbing with CHG, followed by application of a 0.2w/v% CHG with ethanol (HS) preparation. (conventional method); rubbing with CHG and application of HS (two-stage surgical scrub method; TSS); rubbing with anti-septic soap and application of HS (waterless method; WL). Microbial sampling was conducted after hand washing using the glove juice method. No statistically significant differences in bacterial numbers were found among these three methods. The number of bacterially positive subjects was significantly higher in the conventional method than the TSS method. These results indicate that there are adverse effects of blush-scrubbing, as the detected bacteria were related to normal skin flora. As such, the WL method for hand anti-sepsis appears to be equivalent to the conventional surgical scrubbing method in terms of microbial detection. The WL method should therefore be introduced as a standard hand anti-sepsis method at the time of surgery because it is cost-effective as well as time-efficient.
en-copyright=
kn-copyright=

en-aut-name=KobayashiYuka
en-aut-sei=Kobayashi
en-aut-mei=Yuka
kn-aut-name=�¬—Ñ—R‰À
kn-aut-sei=�¬—Ñ
kn-aut-mei=—R‰À
aut-affil-num=1
ORCID=

en-aut-name=YamadaMisa
en-aut-sei=Yamada
en-aut-mei=Misa
kn-aut-name=ŽR“c”ü�²
kn-aut-sei=ŽR“c
kn-aut-mei=”ü�²
aut-affil-num=2
ORCID=

en-aut-name=FujiiHiromi
en-aut-sei=Fujii
en-aut-mei=Hiromi
kn-aut-name=“¡ˆä—T”ü
kn-aut-sei=“¡ˆä
kn-aut-mei=—T”ü
aut-affil-num=3
ORCID=

en-aut-name=KoYukiko
en-aut-sei=Ko
en-aut-mei=Yukiko
kn-aut-name=�b—R‹IŽq
kn-aut-sei=�b
kn-aut-mei=—R‹IŽq
aut-affil-num=4
ORCID=

en-aut-name=UotaniIzumi
en-aut-sei=Uotani
en-aut-mei=Izumi
kn-aut-name=‹›’J‚¢‚ÂÝ
kn-aut-sei=‹›’J
kn-aut-mei=‚¢‚ÂÝ
aut-affil-num=5
ORCID=

en-aut-name=TamotoMariko
en-aut-sei=Tamoto
en-aut-mei=Mariko
kn-aut-name=“c–{�^—�Žq
kn-aut-sei=“c–{
kn-aut-mei=�^—�Žq
aut-affil-num=6
ORCID=

en-aut-name=NadaMasako
en-aut-sei=Nada
en-aut-mei=Masako
kn-aut-name=–¼“c�³Žq
kn-aut-sei=–¼“c
kn-aut-mei=�³Žq
aut-affil-num=7
ORCID=

en-aut-name=MuraiHiroyuki
en-aut-sei=Murai
en-aut-mei=Hiroyuki
kn-aut-name=‘ºˆä—T”V
kn-aut-sei=‘ºˆä
kn-aut-mei=—T”V
aut-affil-num=8
ORCID=

en-aut-name=KadoEi
en-aut-sei=Kado
en-aut-mei=Ei
kn-aut-name=Šp‰p
kn-aut-sei=Šp
kn-aut-mei=‰p
aut-affil-num=9
ORCID=

en-aut-name=IwagakiHiromi
en-aut-sei=Iwagaki
en-aut-mei=Hiromi
kn-aut-name=ŠâŠ_”Ž–¤
kn-aut-sei=ŠâŠ_
kn-aut-mei=”Ž–¤
aut-affil-num=10
ORCID=

en-aut-name=TomodaJun
en-aut-sei=Tomoda
en-aut-mei=Jun
kn-aut-name=—F“c�ƒ
kn-aut-sei=—F“c
kn-aut-mei=�ƒ
aut-affil-num=11
ORCID=

en-aut-name=SaitoShinya
en-aut-sei=Saito
en-aut-mei=Shinya
kn-aut-name=�Ö“¡�M–ç
kn-aut-sei=�Ö“¡
kn-aut-mei=�M–ç
aut-affil-num=12
ORCID=

affil-num=1
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠÅŒì•”

affil-num=2
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠÅŒì•”

affil-num=3
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠÅŒì•”

affil-num=4
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠÅŒì•”

affil-num=5
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠÅŒì•”

affil-num=6
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠÅŒì•”

affil-num=7
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠÅŒì•”

affil-num=8
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@—Õ�°ŒŸ�¸•”

affil-num=9
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@–ò�Ü•”

affil-num=10
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@ŠO‰È

affil-num=11
en-affil=
kn-affil=�‘—§•a‰@‹@�\•ŸŽRˆã—ÃZƒ“ƒ^�[�@“à‰È

affil-num=12
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@•ÛŒ’ŠwŒ¤‹†‰È�@Š´�õŠÇ—�Šw
en-keyword=Žè�ô‚¢ (hand washing)
kn-keyword=Žè�ô‚¢ (hand washing)
en-keyword=ŽèŽw�Á“Å (hand antisepsis)
kn-keyword=ŽèŽw�Á“Å (hand antisepsis)
en-keyword=ƒc�[ƒXƒe�[ƒW�EƒT�[ƒWƒJƒ‹ƒXƒNƒ‰ƒu–@ (surgical scrub method)
kn-keyword=ƒc�[ƒXƒe�[ƒW�EƒT�[ƒWƒJƒ‹ƒXƒNƒ‰ƒu–@ (surgical scrub method)
en-keyword=ƒEƒH�[ƒ^�[ƒŒƒX–@ (waterless method)
kn-keyword=ƒEƒH�[ƒ^�[ƒŒƒX–@ (waterless method)
en-keyword=Žè�p (surgery)
kn-keyword=Žè�p (surgery)
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=219
end-page=223
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=Radiotherapy for choroidal hemangioma
kn-title=–¬—�–ŒŒŒŠÇŽî‚ɑ΂·‚é•úŽË�üŽ¡—Ã
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=PURPOSE: Circumscribed choroidal hemangioma is an uncommon, benign vascular tumor that typically appears in the posterior pole of the eye. Visual acuity loss typically results from its exudation, followed by serous retinal detachment. The purpose of the study was to evaluate the efficacy and the safety of external beam irradiation in treating circumscribed choroidal hemangioma. METHODS: We treated 4 eyes of 4 patients with circumscribed choroidal hemangioma with external beam irradiation at Okayama University Hospital from 2002 to 2009. A total absorbed dose of 20 Gy (beam energy, 4, 10 MV) was applied to each of the 4 patients. Each patient received a single 2-Gy daily fraction for five consecutive days in a week, for two consecutive weeks. RESULTS: In all cases, the retinal detachment showed complete resolution within 8 to 48 days after treatment. A decrease in tumor thickness was observed in all cases except one in which the follow-up period was rather short (3.7 months). The visual acuity improved in all 4 eyes. No eyes showed deterioration of visual acuity. During follow-up periods of 3.7 months to 58.5 months, there were no signs of radiation-induced cataract, retinopathy or optic neuropathy.
en-copyright=
kn-copyright=

en-aut-name=HaradaSosuke
en-aut-sei=Harada
en-aut-mei=Sosuke
kn-aut-name=Œ´“c‘�‰î
kn-aut-sei=Œ´“c
kn-aut-mei=‘�‰î
aut-affil-num=1
ORCID=

en-aut-name=TakemotoMitsuhiro
en-aut-sei=Takemoto
en-aut-mei=Mitsuhiro
kn-aut-name=•�–{�[�L
kn-aut-sei=•�–{
kn-aut-mei=�[�L
aut-affil-num=2
ORCID=

en-aut-name=YoshioKoutarou
en-aut-sei=Yoshio
en-aut-mei=Koutarou
kn-aut-name=‹g”ö�_‘¾˜Y
kn-aut-sei=‹g”ö
kn-aut-mei=�_‘¾˜Y
aut-affil-num=3
ORCID=

en-aut-name=KojimaKatsuhide
en-aut-sei=Kojima
en-aut-mei=Katsuhide
kn-aut-name=Ž™“‡�Ž‰p
kn-aut-sei=Ž™“‡
kn-aut-mei=�Ž‰p
aut-affil-num=4
ORCID=

en-aut-name=KatayamaNorihisa
en-aut-sei=Katayama
en-aut-mei=Norihisa
kn-aut-name=•ÐŽRŒh‹v
kn-aut-sei=•ÐŽR
kn-aut-mei=Œh‹v
aut-affil-num=5
ORCID=

en-aut-name=KatsuiKuniaki
en-aut-sei=Katsui
en-aut-mei=Kuniaki
kn-aut-name=�Ÿˆä–M�²
kn-aut-sei=�Ÿˆä
kn-aut-mei=–M�²
aut-affil-num=6
ORCID=

en-aut-name=KurodaMasahiro
en-aut-sei=Kuroda
en-aut-mei=Masahiro
kn-aut-name=�•“c�¹�G
kn-aut-sei=�•“c
kn-aut-mei=�¹�G
aut-affil-num=7
ORCID=

en-aut-name=MatsuoToshihiko
en-aut-sei=Matsuo
en-aut-mei=Toshihiko
kn-aut-name=�¼”ö�r•F
kn-aut-sei=�¼”ö
kn-aut-mei=�r•F
aut-affil-num=8
ORCID=

en-aut-name=KanazawaSusumu
en-aut-sei=Kanazawa
en-aut-mei=Susumu
kn-aut-name=‹ààV‰E
kn-aut-sei=‹ààV
kn-aut-mei=‰E
aut-affil-num=9
ORCID=

affil-num=1
en-affil=
kn-affil=‰ªŽR‘åŠw•a‰@�@•úŽË�ü‰È

affil-num=2
en-affil=
kn-affil=‰ªŽR‘åŠw•a‰@�@•úŽË�ü‰È

affil-num=3
en-affil=
kn-affil=‰ªŽR‘åŠw•a‰@�@•úŽË�ü‰È

affil-num=4
en-affil=
kn-affil=‰ªŽR‘åŠw•a‰@�@•úŽË�ü‰È

affil-num=5
en-affil=
kn-affil=‰ªŽR‘åŠw•a‰@�@•úŽË�ü‰È

affil-num=6
en-affil=
kn-affil=‰ªŽR‘åŠw•a‰@�@•úŽË�ü‰È

affil-num=7
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@•ÛŒ’ŠwŒ¤‹†‰È�@•úŽË�ü‹Z�p‰ÈŠw•ª–ì

affil-num=8
en-affil=
kn-affil=‰ªŽR‘åŠw•a‰@�@Šá‰È

affil-num=9
en-affil=
kn-affil=‰ªŽR‘åŠw•a‰@�@•úŽË�ü‰È
en-keyword=•úŽË�üŽ¡—à (radiation therapy)
kn-keyword=•úŽË�üŽ¡—à (radiation therapy)
en-keyword=�ÆŽË (irradiation)
kn-keyword=�ÆŽË (irradiation)
en-keyword=–¬—�–Œ (choroid)
kn-keyword=–¬—�–Œ (choroid)
en-keyword=ŠáŽîᇠ(ocular tumor)
kn-keyword=ŠáŽîᇠ(ocular tumor)
en-keyword=ŒŒŠÇŽî (hemangioma)
kn-keyword=ŒŒŠÇŽî (hemangioma)
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=215
end-page=217
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=Radiofrequency ablation of hepatocellular carcinoma in Chugoku-Shikoku district in Japan
kn-title=’†Žl�‘‚É‚¨‚¯‚éŠÌ�×–EŠàƒ‰ƒWƒI”g�ĎܗÖ@‚ÌŒ»�ó
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=The state of radiofrequency ablation for the treatment of hepatocellular carcinoma in Japan's Chugoku-Shikoku district was assessed by a questionnaire completed by 18 participating hospitals. Inclusion criteria of the therapy and the methods of evaluating ablated areas were similar among the 18 hospitals. However, large differences were observed in some questionnaires, in matters such as ablation protocols. These factors may need to be standardized.
en-copyright=
kn-copyright=

en-aut-name=NousoKazuhiro
en-aut-sei=Nouso
en-aut-mei=Kazuhiro
kn-aut-name=”\‘cˆê—T
kn-aut-sei=”\‘c
kn-aut-mei=ˆê—T
aut-affil-num=1
ORCID=

affil-num=1
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@•ªŽqŠÌ‘Ÿ•aŠw
en-keyword=ƒ‰ƒWƒI”g�ĎܗÖ@ (radiofrequency ablation)
kn-keyword=ƒ‰ƒWƒI”g�ĎܗÖ@ (radiofrequency ablation)
en-keyword=ŠÌ�×–EŠà (hepatocellular carcinoma)
kn-keyword=ŠÌ�×–EŠà (hepatocellular carcinoma)
en-keyword=Ž¡—Ã (therapy)
kn-keyword=Ž¡—Ã (therapy)
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=209
end-page=213
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=Development of innovative therapies for gastrointestinal cancer
kn-title=�Á‰»Ší‚ª‚ñŽ¡—Âɂ¨‚¯‚é�æ’[ˆã—ÊJ”­
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=
en-copyright=
kn-copyright=

en-aut-name=FujiwaraToshiyoshi
en-aut-sei=Fujiwara
en-aut-mei=Toshiyoshi
kn-aut-name=“¡Œ´�r‹`
kn-aut-sei=“¡Œ´
kn-aut-mei=�r‹`
aut-affil-num=1
ORCID=

affil-num=1
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@�Á‰»Ší�EŽîᇊO‰ÈŠw
en-keyword=�Á‰»Ší‚ª‚ñ
kn-keyword=�Á‰»Ší‚ª‚ñ
en-keyword=ƒeƒ�ƒ�ƒ‰�[ƒ[
kn-keyword=ƒeƒ�ƒ�ƒ‰�[ƒ[
en-keyword=ƒAƒfƒmƒEƒCƒ‹ƒX
kn-keyword=ƒAƒfƒmƒEƒCƒ‹ƒX
en-keyword=ŠO‰ÈƒiƒrƒQ�[ƒVƒ‡ƒ“
kn-keyword=ŠO‰ÈƒiƒrƒQ�[ƒVƒ‡ƒ“
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=203
end-page=208
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=Development of novel detecting systems and therapies for micro cancer using replication-competent oncolytic adenovirus
kn-title=�§ŒÀ‘��BŒ^ƒAƒfƒmƒEƒCƒ‹ƒX�»�Ü‚ð—p‚¢‚½�V‚½‚È”÷�¬‚ª‚ñ•a•Ï‚ÌŒŸ�o–@‚ÌŠJ”­‚ÆŽ¡—Âւ̉ž—p
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=
en-copyright=
kn-copyright=

en-aut-name=KojimaToru
en-aut-sei=Kojima
en-aut-mei=Toru
kn-aut-name=Ž™“‡‹œ
kn-aut-sei=Ž™“‡
kn-aut-mei=‹œ
aut-affil-num=1
ORCID=

en-aut-name=HashimotoYuuri
en-aut-sei=Hashimoto
en-aut-mei=Yuuri
kn-aut-name=‹´–{—I—¢
kn-aut-sei=‹´–{
kn-aut-mei=—I—¢
aut-affil-num=2
ORCID=

en-aut-name=KagawaShunsuke
en-aut-sei=Kagawa
en-aut-mei=Shunsuke
kn-aut-name=���ì�r•ã
kn-aut-sei=���ì
kn-aut-mei=�r•ã
aut-affil-num=3
ORCID=

en-aut-name=TanakaNoriaki
en-aut-sei=Tanaka
en-aut-mei=Noriaki
kn-aut-name=“c’†‹I�Í
kn-aut-sei=“c’†
kn-aut-mei=‹I�Í
aut-affil-num=4
ORCID=

en-aut-name=UrataYasuo
en-aut-sei=Urata
en-aut-mei=Yasuo
kn-aut-name=‰Y“c‘×�¶
kn-aut-sei=‰Y“c
kn-aut-mei=‘×�¶
aut-affil-num=5
ORCID=

en-aut-name=FujiwaraToshiyoshi
en-aut-sei=Fujiwara
en-aut-mei=Toshiyoshi
kn-aut-name=“¡Œ´�r‹`
kn-aut-sei=“¡Œ´
kn-aut-mei=�r‹`
aut-affil-num=6
ORCID=

affil-num=1
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@�Á‰»Ší�EŽîᇊO‰ÈŠw

affil-num=2
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@�Á‰»Ší�EŽîᇊO‰ÈŠw

affil-num=3
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@�Á‰»Ší�EŽîᇊO‰ÈŠw

affil-num=4
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@�Á‰»Ší�EŽîᇊO‰ÈŠw

affil-num=5
en-affil=
kn-affil=ƒIƒ“ƒRƒŠƒXƒoƒCƒIƒtƒ@�[ƒ}

affil-num=6
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@�Á‰»Ší�EŽîᇊO‰ÈŠw
en-keyword=telomerase
kn-keyword=telomerase
en-keyword=oncolytic adenovirus
kn-keyword=oncolytic adenovirus
en-keyword=GFP
kn-keyword=GFP
en-keyword=micrometastasis
kn-keyword=micrometastasis
en-keyword=circulating tumor cell
kn-keyword=circulating tumor cell
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=199
end-page=202
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=Neuronal cilia in pericentrin mutant mice
kn-title=Pericentrin•ÏˆÙƒ}ƒEƒX‚É‚¨‚¯‚é�_ŒoŒn‘@–Ñ
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=Pericentrinˆâ“`Žq‚Ƀzƒ‚‚ŕψقðŽ�‚ƒ}ƒEƒX�iƒzƒ‚•ÏˆÙƒ}ƒEƒX�j‚Å‚Í’†�•�_ŒoŒn‚PŽŸ‘@–Ñ‚¨‚æ‚ÑškŠo�_Œo�×–E‚Ìšk‘@–Ñ‚Ì’áŒ`�¬‚ªŠÏŽ@‚³‚ꂽ�DŽ©”­‰^“®—Ê�C•sˆÀŠÖ˜A�s“®‚¨‚æ‚ÑŠC”nŽ•�ó‰ñè÷—±�×–E‰º‘w‚Å‚Ì�_Œo�V�¶‚Í�Cƒzƒ‚•ÏˆÙƒ}ƒEƒX‚Æ–ì�¶Œ^ƒ}ƒEƒX‚ÌŠÔ‚Å—LˆÓ‚È�·ˆÙ‚ð”F‚ß‚È‚©‚Á‚½�Dˆê•û�Cƒzƒ‚•ÏˆÙƒ}ƒEƒX‚ÍškŠo‹@”\‚̒ቺ‚ɉÁ‚¦‚Ä�R‚¤‚Â�s“®‚ðŽ¦‚µ‚½‚±‚Æ‚©‚ç�C’†�•�_ŒoŒn‚PŽŸ‘@–Ñ‚Ì’áŒ`�¬‚Í�R‚¤‚ÂŒø‰Ê‚ðŽ�‚‚Æ�l‚¦‚ç‚ꂽ�D
en-copyright=
kn-copyright=

en-aut-name=MiyoshiKo
en-aut-sei=Miyoshi
en-aut-mei=Ko
kn-aut-name=ŽO�D�k
kn-aut-sei=ŽO�D
kn-aut-mei=�k
aut-affil-num=1
ORCID=

affil-num=1
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@�_Œo�î•ñŠw
en-keyword=�_ŒoŒn‘@–Ñ
kn-keyword=�_ŒoŒn‘@–Ñ
en-keyword=pericentrin
kn-keyword=pericentrin
en-keyword=škŠo
kn-keyword=škŠo
en-keyword=�R‚¤‚Â
kn-keyword=�R‚¤‚Â
END

start-ver=1.4
cd-journal=joma
no-vol=122
cd-vols=
no-issue=3
article-no=
start-page=195
end-page=197
dt-received=
dt-revised=
dt-accepted=
dt-pub-year=2010
dt-pub=20101201
dt-online=
en-article=
kn-article=
en-subject=
kn-subject=
en-title=Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain
kn-title=ƒ‰ƒbƒg�oŒŒ�«�[�ǃ‚ƒfƒ‹‚É‚¨‚¯‚éƒGƒ_ƒ‰ƒ{ƒ“‚Ìneurovascular unit•ÛŒìŒø‰Ê
en-subtitle=
kn-subtitle=
en-abstract=
kn-abstract=
en-copyright=
kn-copyright=

en-aut-name=YamashitaToru
en-aut-sei=Yamashita
en-aut-mei=Toru
kn-aut-name=ŽR‰º“O
kn-aut-sei=ŽR‰º
kn-aut-mei=“O
aut-affil-num=1
ORCID=

en-aut-name=KamiyaTatsushi
en-aut-sei=Kamiya
en-aut-mei=Tatsushi
kn-aut-name=�_’J’BŽi
kn-aut-sei=�_’J
kn-aut-mei=’BŽi
aut-affil-num=2
ORCID=

en-aut-name=DeguchiKentaro
en-aut-sei=Deguchi
en-aut-mei=Kentaro
kn-aut-name=�oŒûŒ’‘¾˜Y
kn-aut-sei=�oŒû
kn-aut-mei=Œ’‘¾˜Y
aut-affil-num=3
ORCID=

en-aut-name=InabaToshiki
en-aut-sei=Inaba
en-aut-mei=Toshiki
kn-aut-name=ˆî—t�r“Œ
kn-aut-sei=ˆî—t
kn-aut-mei=�r“Œ
aut-affil-num=4
ORCID=

en-aut-name=ZhangHanzhe
en-aut-sei=Zhang
en-aut-mei=Hanzhe
kn-aut-name=’£Š¿“N
kn-aut-sei=’£
kn-aut-mei=Š¿“N
aut-affil-num=5
ORCID=

en-aut-name=ShangJingwei
en-aut-sei=Shang
en-aut-mei=Jingwei
kn-aut-name=�¤ŒhˆÌ
kn-aut-sei=�¤
kn-aut-mei=ŒhˆÌ
aut-affil-num=6
ORCID=

en-aut-name=MiyazakiKazunori
en-aut-sei=Miyazaki
en-aut-mei=Kazunori
kn-aut-name=‹{�èˆê“¿
kn-aut-sei=‹{�è
kn-aut-mei=ˆê“¿
aut-affil-num=7
ORCID=

en-aut-name=OhtsukaAiji
en-aut-sei=Ohtsuka
en-aut-mei=Aiji
kn-aut-name=‘å’ˈ¤“ñ
kn-aut-sei=‘å’Ë
kn-aut-mei=ˆ¤“ñ
aut-affil-num=8
ORCID=

en-aut-name=KatayamaYasuo
en-aut-sei=Katayama
en-aut-mei=Yasuo
kn-aut-name=•ÐŽR‘טN
kn-aut-sei=•ÐŽR
kn-aut-mei=‘טN
aut-affil-num=9
ORCID=

en-aut-name=AbeKoji
en-aut-sei=Abe
en-aut-mei=Koji
kn-aut-name=ˆ¢•”�N“ñ
kn-aut-sei=ˆ¢•”
kn-aut-mei=�N“ñ
aut-affil-num=10
ORCID=

affil-num=1
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@”]�_Œo“à‰ÈŠw

affil-num=2
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@”]�_Œo“à‰ÈŠw

affil-num=3
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@”]�_Œo“à‰ÈŠw

affil-num=4
en-affil=
kn-affil=“ú–{ˆã‰È‘åŠw�@‘æ“ñ“à‰È

affil-num=5
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@”]�_Œo“à‰ÈŠw

affil-num=6
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@”]�_Œo“à‰ÈŠw

affil-num=7
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@”]�_Œo“à‰ÈŠw

affil-num=8
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@�l‘Ì�\�¬Šw

affil-num=9
en-affil=
kn-affil=“ú–{ˆã‰È‘åŠw�@‘æ“ñ“à‰È

affil-num=10
en-affil=
kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�@”]�_Œo“à‰ÈŠw
en-keyword=�oŒŒ�«�[�Ç (hemorrhagic transformation)
kn-keyword=�oŒŒ�«�[�Ç (hemorrhagic transformation)
en-keyword=tPA (tissue plasminogen activator)
kn-keyword=tPA (tissue plasminogen activator)
en-keyword=MMP-9 (matrix metalloproteinase-9)
kn-keyword=MMP-9 (matrix metalloproteinase-9)
en-keyword=ƒtƒŠ�[ƒ‰ƒWƒJƒ‹ (free radical)
kn-keyword=ƒtƒŠ�[ƒ‰ƒWƒJƒ‹ (free radical)
en-keyword=ƒGƒ_ƒ‰ƒ{ƒ“ (edaravone)
kn-keyword=ƒGƒ_ƒ‰ƒ{ƒ“ (edaravone)
END